Insights & Analysis

Industry insights that are curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.

Page 17

M&A

Whiting, Oasis Finally Link Up in Bakken

By Tom Terrarosa
|
Published: March 21st, 2022
The pair announce a $6 billion merger after The Deal predicted in August that the companies had arrived at the perfect place to enact a long-anticipated combination.
Activism

Caligan Hovers Amid ADMA Review

By Armie Margaret Lee
|
Published: March 18th, 2022
The investment firm is unlikely to launch a contest, though it is focused on a successful outcome from the company's ongoing strategic review with Morgan Stanley.
M&A

Restaurants Catch Up on Tech

By Nikitha Sattiraju
|
Published: February 18th, 2022
Demand for new technology drives M&A, turning the attention to PE-backed companies such as HungerRush as acquirers and opportunities.
Activism

Kohl’s Retains Goldman, Rejects Bids

By Ronald Orol
|
Published: February 4th, 2022
The activist-targeted department store chain rejects expressions of interest while noting it has retained Goldman Sachs — first reported last month in The Deal — to engage with interested parties.
M&A

Drinks With The Deal: Katten's Kimberly Smith

By David Marcus
|
Published: February 3rd, 2022
Kimberly Smith, head of the law firm's corporate department, discusses the current state of middle-market dealmaking, her work with family offices and increased regulatory scrutiny of even smaller deals.
M&A

CI Capital Sells Epiphany Dermatology

By Armie Margaret Lee
|
Published: February 3rd, 2022
The Deal reported in October that the PE firm was exploring a sale of the Austin, Texas-based dermatology company.